Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | beta-site APP-cleaving enzyme 1 | Starlite/ChEMBL | References |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Schistosoma mansoni | memapsin-2 (A01 family) | Get druggable targets OG5_135830 | All targets in OG5_135830 |
Schistosoma japonicum | ko:K07747 beta-site APP-cleaving enzyme 2 (memapsin 1) [EC3.4.23.45], putative | Get druggable targets OG5_135830 | All targets in OG5_135830 |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Plasmodium falciparum | plasmepsin VII | beta-site APP-cleaving enzyme 1 | 401 aa | 352 aa | 21.3 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Mycobacterium tuberculosis | Polyketide synthase Pks13 | 0.0355 | 0.6289 | 1 |
Loa Loa (eye worm) | fatty acid synthase | 0.0234 | 0.3598 | 0.4318 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsE | 0.0157 | 0.1874 | 0.2981 |
Mycobacterium tuberculosis | Probable fatty acid synthase Fas (fatty acid synthetase) | 0.0075 | 0.0035 | 0.0056 |
Mycobacterium tuberculosis | Probable membrane bound polyketide synthase Pks6 | 0.0355 | 0.6289 | 1 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0252 | 0.3998 | 1 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks7 | 0.0252 | 0.3998 | 0.6357 |
Mycobacterium tuberculosis | Polyketide synthase Pks2 | 0.023 | 0.3506 | 0.5576 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSD | 0.0237 | 0.3669 | 0.581 |
Mycobacterium ulcerans | polyketide synthase | 0.0252 | 0.3998 | 0.6357 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0237 | 0.3669 | 0.5834 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0237 | 0.3669 | 0.5834 |
Mycobacterium leprae | Probable polyketide synthase Pks1 | 0.0252 | 0.3998 | 0.6337 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0237 | 0.3669 | 0.5834 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks5 | 0.023 | 0.3506 | 0.5576 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsA | 0.0191 | 0.2634 | 0.4188 |
Loa Loa (eye worm) | hypothetical protein | 0.0133 | 0.1339 | 0.0823 |
Brugia malayi | Beta-ketoacyl synthase, N-terminal domain containing protein | 0.0237 | 0.3669 | 0.4361 |
Brugia malayi | oxidoreductase, zinc-binding dehydrogenase family protein | 0.045 | 0.8412 | 1 |
Loa Loa (eye worm) | AMP-binding enzyme family protein | 0.0222 | 0.3321 | 0.3889 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks8 | 0.0194 | 0.2703 | 0.4299 |
Mycobacterium ulcerans | polyketide synthase | 0.0237 | 0.3669 | 0.5834 |
Toxoplasma gondii | beta-ketoacyl synthase, N-terminal domain-containing protein | 0.0154 | 0.1808 | 0.2574 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSE | 0.0157 | 0.1874 | 0.2941 |
Mycobacterium ulcerans | fatty acid synthase Fas | 0.0075 | 0.0035 | 0.0056 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks1 | 0.017 | 0.2177 | 0.3461 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSB | 0.0191 | 0.2634 | 0.4155 |
Mycobacterium ulcerans | polyketide synthase Pks13 | 0.0355 | 0.6289 | 1 |
Mycobacterium ulcerans | polyketide synthase Pks9 | 0.0157 | 0.1874 | 0.2981 |
Brugia malayi | AMP-binding enzyme family protein | 0.0222 | 0.3321 | 0.3948 |
Mycobacterium tuberculosis | Polyketide synthase Pks12 | 0.0252 | 0.3998 | 0.6357 |
Mycobacterium ulcerans | thioesterase | 0.0198 | 0.2786 | 0.443 |
Mycobacterium ulcerans | thioesterase TesA | 0.0198 | 0.2786 | 0.443 |
Toxoplasma gondii | type I fatty acid synthase, putative | 0.0169 | 0.2142 | 0.3708 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSC | 0.0252 | 0.3998 | 0.6337 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks9 | 0.0135 | 0.1383 | 0.2199 |
Mycobacterium leprae | PHENOLPTHIOCEROL SYNTHESIS TYPE-I POLYKETIDE SYNTHASE PPSA | 0.0237 | 0.3669 | 0.581 |
Mycobacterium leprae | Probable multifunctional mycocerosic acid synthase membrane associated enzyme Mas | 0.0252 | 0.3998 | 0.6337 |
Mycobacterium leprae | Polyketide synthase Pks13 | 0.0355 | 0.6289 | 1 |
Mycobacterium ulcerans | Type I modular polyketide synthase | 0.0237 | 0.3669 | 0.5834 |
Mycobacterium tuberculosis | Phenyloxazoline synthase MbtB (phenyloxazoline synthetase) | 0.0222 | 0.3321 | 0.528 |
Loa Loa (eye worm) | hypothetical protein | 0.0399 | 0.727 | 1 |
Onchocerca volvulus | 0.0413 | 0.7592 | 0.9285 | |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0237 | 0.3669 | 0.5834 |
Mycobacterium tuberculosis | Polyketide synthetase MbtC (polyketide synthase) | 0.0082 | 0.0192 | 0.0306 |
Onchocerca volvulus | Fatty acid synthase homolog | 0.0428 | 0.7921 | 1 |
Mycobacterium tuberculosis | Probable multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0252 | 0.3998 | 0.6357 |
Mycobacterium tuberculosis | Probable polyketide synthase Pks15 | 0.0096 | 0.0513 | 0.0817 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0252 | 0.3998 | 0.6357 |
Mycobacterium ulcerans | phenolpthiocerol synthesis type-I polyketide synthase PpsB | 0.0191 | 0.2634 | 0.4188 |
Mycobacterium tuberculosis | Probable thioesterase TesA | 0.0198 | 0.2786 | 0.443 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsD | 0.0237 | 0.3669 | 0.5834 |
Mycobacterium tuberculosis | Phenolpthiocerol synthesis type-I polyketide synthase PpsC | 0.0237 | 0.3669 | 0.5834 |
Mycobacterium leprae | PROBABLE THIOESTERASE TESA | 0.0198 | 0.2786 | 0.4398 |
Mycobacterium ulcerans | multifunctional mycocerosic acid synthase membrane-associated Mas | 0.0252 | 0.3998 | 0.6357 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
IC50 (binding) | = 79 nM | Inhibition of BACE-1 in HEK293 cells expressing APP assessed as reduction in amyloid beta (1 to 40) level after 48 hrs by HTRF assay | ChEMBL. | 24397738 |
IC50 (binding) | = 220 nM | Inhibition of human recombinant BACE-1 expressed in CHO cells using biotinylated P10 to P17' peptide as substrate preincubated for 15 mins followed by substrate addition measured after 2 hrs by HTRF assay | ChEMBL. | 24397738 |
IC50 (binding) | = 57000 nM | Inhibition of human liver cathepsin D measured for 1 hr by FRET assay | ChEMBL. | 24397738 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.